Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001415889-16-007569

CEO, PRESIDENT bought 2,000 shares at $2.42 ($4,840)

From the SEC's structured data for this filing

Trades in this filing

Jaksch Frank L Jr · CEO, PRESIDENT

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-12-12 Purchase : show line 1 in the form +2,000 $2.42 $4,840 201,557 D
Open-market purchases · 2,000 sh · avg $2.42 · $4,840
Loading xslF345X03/form4-12122016_011209.xml…